About this item:

312 Views | 119 Downloads

Author Notes:

Corresponding author: Emily J. Weston, vog.cdc@notsewe, 404-639-3603: eweston@cdc.gov

Christina Schumacher, Baltimore City Health Department; Heidi Bauer, Joan Chow, Emily Han, California Department of Public Health; Craig Wilson, Sonya du Bernard, Lisa Thompson, Florida Department of Health; Kathleen Hsu, Heather Elder, Massachusetts Department of Public Health; Krissie Guerard, Dawn Ginzl, Laura Tourdot, Minnesota Department of Health; Lenore Asbel, Greta Anschuetz, Robbie Madera, Philadelphia Department of Public Health; Gail Bolan, Jim Braxton, Brian Emerson, LaZetta Grier, Eloisa Llata, Tremeka Sanders, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC

No conflicts of interest were reported.

Subjects:

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Public, Environmental & Occupational Health
  • NEISSERIA-GONORRHOEAE
  • TREATMENT-GUIDELINES
  • RESISTANCE

Adherence to CDC Recommendations for the Treatment of Uncomplicated Gonorrhea - STD Surveillance Network, United States, 2016

Tools:

Journal Title:

MMWR. Morbidity and mortality weekly report

Volume:

Volume 67, Number 16

Publisher:

, Pages 473-476

Type of Work:

Article | Final Publisher PDF

Abstract:

What is already known about this topic? CDC’s treatment recommendations for gonorrhea were revised in 2012 and 2015 based on emerging antimicrobial resistance. What is added by this report? In 2016, 81% of gonorrhea cases in seven jurisdictions were treated with the recommended regimen for uncomplicated gonorrhea (250 mg dose of ceftriaxone [IM] plus 1 g dose of azithromycin [PO]), but this varied by provider type. What are the implications for public health practice? Providers should be aware of the national guidelines for the treatment of sexually transmitted infections. Monitoring of treatment practices is a critical public health priority to help assure that patients receive the highest quality of care, and to address the emerging threat of antimicrobial-resistant gonorrhea.

Copyright information:

© 2018, Department of Health and Human Services. All rights reserved.

This is an Open Access work distributed under the terms of the Creative Commons Universal : Public Domain Dedication License (http://creativecommons.org/publicdomain/zero/1.0/).

Creative Commons License

Export to EndNote